Rigel Pharmaceuticals SG&A Expense (Quarterly) Insights

Rigel Pharmaceuticals Inc (RIGL)

1.125 -0.02 (-1.32%) USD | NASDAQ | Apr 24, 16:00

1.13 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2001. Upgrade now.

Date	Value
December 31, 2023	26.85M
September 30, 2023	24.86M
June 30, 2023	26.31M
March 31, 2023	27.73M
December 31, 2022	32.17M
September 30, 2022	25.90M
June 30, 2022	26.98M
March 31, 2022	27.40M
December 31, 2021	24.52M
September 30, 2021	22.88M
June 30, 2021	22.38M
March 31, 2021	22.12M
December 31, 2020	21.82M
September 30, 2020	17.43M
June 30, 2020	18.92M
March 31, 2020	18.43M
December 31, 2019	18.31M
September 30, 2019	18.12M
June 30, 2019	18.21M
March 31, 2019	19.95M
December 31, 2018	21.37M
September 30, 2018	18.07M
June 30, 2018	17.07M
March 31, 2018	13.49M
December 31, 2017	14.65M

Date	Value
September 30, 2017	7.947M
June 30, 2017	7.82M
March 31, 2017	7.41M
December 31, 2016	7.153M
September 30, 2016	4.558M
June 30, 2016	4.774M
March 31, 2016	4.423M
December 31, 2015	4.721M
September 30, 2015	4.276M
June 30, 2015	4.099M
March 31, 2015	4.717M
December 31, 2014	16.00M
September 30, 2014	4.889M
June 30, 2014	5.393M
March 31, 2014	5.516M
December 31, 2013	4.648M
September 30, 2013	4.677M
June 30, 2013	4.892M
March 31, 2013	5.395M
December 31, 2012	5.852M
September 30, 2012	5.383M
June 30, 2012	5.458M
March 31, 2012	6.156M
December 31, 2011	6.091M
September 30, 2011	5.08M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

17.43M

Minimum

Sep 2020

32.17M

Maximum

Dec 2022

23.23M

Average

22.88M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks